Thomas Mika

Executive Vice President and CFO,

POET Technologies

About Thomas

Thomas Mika joined POET in November 2016. He previously served as the chairman of the board of Rennova Health, the successor company to CollabRx and previously Tegal Corporation. Following Tegal's spin-out from Motorola in 1989, Mr. Mika assumed the roles of CFO in 2002, CEO in 2005, and Chairman and CEO in 2006. Previously, he co-founded IMTEC, a boutique investment and consulting firm, serving international clients over a period of 20 years. Mr. Mika holds a Bachelor of Science in Microbiology from the University of Illinois at Urbana-Champaign and a Master of Business Administration from the Harvard Graduate School of Business.

Thomas's Videos

POET Technologies is a leader in the silicon photonics trend that's changing the semiconductor game-moving data at light speed for today's data-hungry technologies. POET is taking optical data transmission to the next level with our proven method for efficiently integrating photonics and electronics. The centerpiece: our patented Optical Interposer, which consolidates components onto a single, scalable platform that dramatically reduces assembly time and cuts costs by as much as half. In short, POET is lighting the way in hybrid silicon photonics-for applications ranging from data centers to health sensors, IoT to 5G, and AI to EV.
POET Technologies is disrupting the long-held paradigm of optical devices being painstakingly manufactured one-at-a-time by bringing proven semiconductor economics and scalability to optoelectronics solutions. In addition to enabling unprecedented improvements in energy efficiency, component cost and size for next-generation, and high-speed data communications, POET's Optical Interposer Platform addresses enormous emerging opportunities in edge computing, artificial intelligence, medical, and autonomous vehicles.